![New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond - ScienceDirect New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168827815001336-gr2.jpg)
New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond - ScienceDirect
![Ursodeoxycholic acid: Mechanism of action and novel clinical applications - Ikegami - 2008 - Hepatology Research - Wiley Online Library Ursodeoxycholic acid: Mechanism of action and novel clinical applications - Ikegami - 2008 - Hepatology Research - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ba5cdf70-4a18-4528-8d09-4fbd82773515/hepr_297_f3.gif)
Ursodeoxycholic acid: Mechanism of action and novel clinical applications - Ikegami - 2008 - Hepatology Research - Wiley Online Library
![Ursodeoxycholic acid: a promising therapeutic target for inflammatory bowel diseases? | American Journal of Physiology-Gastrointestinal and Liver Physiology Ursodeoxycholic acid: a promising therapeutic target for inflammatory bowel diseases? | American Journal of Physiology-Gastrointestinal and Liver Physiology](https://journals.physiology.org/cms/10.1152/ajpgi.00163.2019/asset/images/medium/zh30101976760001.gif)
Ursodeoxycholic acid: a promising therapeutic target for inflammatory bowel diseases? | American Journal of Physiology-Gastrointestinal and Liver Physiology
![Frontiers | Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome Frontiers | Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome](https://www.frontiersin.org/files/Articles/401908/fphar-09-01382-HTML/image_m/fphar-09-01382-g001.jpg)
Frontiers | Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
![Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction | Scientific Reports Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-018-30349-1/MediaObjects/41598_2018_30349_Fig7_HTML.png)
Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction | Scientific Reports
![Does ursodeoxycholic acid improve perinatal outcomes in women with intrahepatic cholestasis of pregnancy? | The BMJ Does ursodeoxycholic acid improve perinatal outcomes in women with intrahepatic cholestasis of pregnancy? | The BMJ](https://www.bmj.com/content/bmj/360/bmj.k104/F2.large.jpg)
Does ursodeoxycholic acid improve perinatal outcomes in women with intrahepatic cholestasis of pregnancy? | The BMJ
![Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis | Nature Reviews Gastroenterology & Hepatology Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fncpgasthep0521/MediaObjects/41575_2006_Article_BFncpgasthep0521_Fig2_HTML.jpg)
Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis | Nature Reviews Gastroenterology & Hepatology
![Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis - ScienceDirect Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000629521930228X-ga1.jpg)
Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis - ScienceDirect
Sex-, age-, and organ-dependent improvement of bile acid hydrophobicity by ursodeoxycholic acid treatment: A study using a mouse model with human-like bile acid composition | PLOS ONE
![PDF] Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications. | Semantic Scholar PDF] Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/97e0a9226e5e95b66fdf49b1c3823f2f2477e705/12-Figure5-1.png)
PDF] Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications. | Semantic Scholar
![Cost effectiveness of using ursodeoxycholic acid to treat primary biliary cholangitis | British Journal of Hospital Medicine Cost effectiveness of using ursodeoxycholic acid to treat primary biliary cholangitis | British Journal of Hospital Medicine](https://www.magonlinelibrary.com/cms/10.12968/hmed.2018.79.8.460/asset/images/medium/hmed.2018.79.8.460_t01.jpg)
Cost effectiveness of using ursodeoxycholic acid to treat primary biliary cholangitis | British Journal of Hospital Medicine
![Mechanism of action of three potential therapeutic drugs-ursolic acid,... | Download Scientific Diagram Mechanism of action of three potential therapeutic drugs-ursolic acid,... | Download Scientific Diagram](https://www.researchgate.net/publication/311917773/figure/fig1/AS:443902764294144@1482846074276/Mechanism-of-action-of-three-potential-therapeutic-drugs-ursolic-acid.png)
Mechanism of action of three potential therapeutic drugs-ursolic acid,... | Download Scientific Diagram
![New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond - ScienceDirect New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168827815001336-gr1.jpg)
New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond - ScienceDirect
![Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial | The BMJ Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial | The BMJ](https://www.bmj.com/content/bmj/344/bmj.e3799/F1.large.jpg)